Skip to main content

Bear market coming, gold(GLD) assets become essential

gold

The economic data of the global economic powers have been deteriorating, entering the bear market stage of the economy, and people have become more cautious when choosing asset investment.

We should choose investment products with a low correlation coefficient with economic performance and investment products suitable for the current economic cycle. Investors should pay more attention to foreign exchange and commodity markets so that they can add value to your assets.

Among many assets, anti-inflation commodities such as gold have become essential assets.

Take gold as an example. For many years, gold has been regarded as an anti-inflation commodity by international capital markets and has been regarded as an important asset hedging tool by investors.

There is also a saying, "The world bought gold during turbulent times." From basic political theory, we know that gold is not currency, and the currency is naturally gold and silver.

Although gold has withdrawn from the market as a currency, its attributes as a currency still exist. The credit currency circulating in the market is based on the commitment of a country, and the currency itself is worthless.

In other words, the state promises to convert currency into commodities of corresponding value. Therefore, when a country experiences a credit crisis, it will trigger a currency crisis and the currency in circulation is likely to be worthless.

But gold is not based on national credit, it has high value itself, so it can survive the crisis.

With the risk aversion further heating up, gold is expected to continue to rise.

Gold price weekly chart
Gold price weekly chart

In terms of technical analysis, the weekly gold price chart is in an upward phase and should continue to be held.

Through the following simple model of gold, The reasonable price of gold is more than $2,500.

Comments

Popular posts from this blog

Moderna stock forecast 2025: MRNA is worth buying for 5 reasons

Moderna was founded in 2009 and was established in Cambridge, Massachusetts, USA. Its main business is genetic engineering and focuses on the research and development of mRNA-derived drugs. The full name of mRNA is messenger RNA, pre-messenger RNA, a kind of immature single-stranded messenger ribonucleic acid, once it is completely processed, it is called "mature messenger RNA", or "mRNA". These drugs use mRNA as a treatment method and use mRNA as the basis to inject the developed synthetic mRNA into the patient's body so that the patient's own cells can obtain the ability to treat themselves. At present, the new crown vaccine being researched and developed by Moderna has an effective rate of 94.5%, so it has become one of the vaccines that are sold in large quantities all over the world. Cambridge, Massachusetts, is not only home to Harvard University but also a world-renowned hot spot for modern biomedicine. Despite such a "gorgeous background", ...